CA2331781A1 - Genes a cytosine methyltransferase d'adn adventif, polypeptides et leur utilisation - Google Patents

Genes a cytosine methyltransferase d'adn adventif, polypeptides et leur utilisation Download PDF

Info

Publication number
CA2331781A1
CA2331781A1 CA002331781A CA2331781A CA2331781A1 CA 2331781 A1 CA2331781 A1 CA 2331781A1 CA 002331781 A CA002331781 A CA 002331781A CA 2331781 A CA2331781 A CA 2331781A CA 2331781 A1 CA2331781 A1 CA 2331781A1
Authority
CA
Canada
Prior art keywords
polypeptides
novo dna
cytosine methyltransferase
dna cytosine
methyltransferase genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002331781A
Other languages
English (en)
Other versions
CA2331781C (fr
Inventor
En Li
Masaki Okano
Shaoping Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2331781A1 publication Critical patent/CA2331781A1/fr
Application granted granted Critical
Publication of CA2331781C publication Critical patent/CA2331781C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002331781A 1998-06-25 1999-06-25 Genes a cytosine methyltransferase d'adn adventif, polypeptides et leur utilisation Expired - Fee Related CA2331781C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9090698P 1998-06-25 1998-06-25
US60/090,906 1998-06-25
US9399398P 1998-07-24 1998-07-24
US60/093,993 1998-07-24
PCT/US1999/014373 WO1999067397A1 (fr) 1998-06-25 1999-06-25 Genes a cytosine methyltransferase d'adn adventif, polypeptides et leur utilisation

Publications (2)

Publication Number Publication Date
CA2331781A1 true CA2331781A1 (fr) 1999-12-29
CA2331781C CA2331781C (fr) 2008-01-08

Family

ID=26782776

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002331781A Expired - Fee Related CA2331781C (fr) 1998-06-25 1999-06-25 Genes a cytosine methyltransferase d'adn adventif, polypeptides et leur utilisation

Country Status (2)

Country Link
CA (1) CA2331781C (fr)
WO (1) WO1999067397A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE471150T1 (de) 1996-03-26 2010-07-15 Kopreski Michael S Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden
US8043835B1 (en) 1996-03-26 2011-10-25 Oncomedx, Inc. Methods for detecting and monitoring cancer using extracellular RNA
US7785842B2 (en) 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US6759217B2 (en) 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US8440396B2 (en) 1997-03-14 2013-05-14 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US8163524B2 (en) 1998-09-22 2012-04-24 Oncomedx, Inc. Comparative analysis of extracellular RNA species
WO2001027249A1 (fr) * 1999-10-15 2001-04-19 Fit Biotech Oyj Plc Nouveau gene codant une adn methyltransferase dnmt3l
EP1384787A1 (fr) * 2002-07-25 2004-01-28 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Procédé de criblage pour l'identification et la charactérisation d'inhibiteurs d'ADN méthyltransférase
US7405287B2 (en) * 2004-08-03 2008-07-29 Board Of Regents, The University Of Texas System Method of treating a cancer

Also Published As

Publication number Publication date
WO1999067397A1 (fr) 1999-12-29
CA2331781C (fr) 2008-01-08

Similar Documents

Publication Publication Date Title
CA2194393A1 (fr) Telomerase mammifere
AU2086199A (en) Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
AU3560399A (en) Tumor associated nucleic acids and uses therefor
AU4903101A (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU4095999A (en) Cell cycle genes, proteins and uses thereof
AU5552396A (en) Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof
WO1996001614A3 (fr) Composant d'arn de la telomerase
EP1024153A4 (fr) Polymere, procede de production dudit polymere et composition durcissable contenant ledit polymere
AU2882299A (en) Anti-asthma therapy
WO2000018914A3 (fr) NOUVEAUX POLYPEPTIDES $i(DKR)
AU3931300A (en) Methods for identifying pathway-specific reporters and target genes, and uses thereof
CA2331781A1 (fr) Genes a cytosine methyltransferase d'adn adventif, polypeptides et leur utilisation
AU6257298A (en) Breast cancer specific gene 1
IL158159A0 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-21 GENE
AU8669598A (en) Chemokine receptor ccr8 dna and uses thereof
WO1997020045A3 (fr) Nouveau recepteur purinergique p2u2
WO2001042474A3 (fr) Molecules de type interferon et utilisations
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
WO2001064837A3 (fr) NETRINE β ET SES UTILISATIONS
WO1998033937A3 (fr) SEQUENCE GENOMIQUE DU GENE RECEPTEUR ν-OPIOIDE HUMAIN, AINSI QUE SES VARIANTES, POLYMORPHISMES ET MUTATIONS
CA2369825A1 (fr) Composants microstructures
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU7983298A (en) Disease related nucleotide kinases
EP1158006A4 (fr) Polymere, procede de preparation du polymere, et composition durcissable contenant le polymere
AU3673500A (en) Fine particles targeting cells and process for producing the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed